These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9920756)

  • 21. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
    Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA
    Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-specific regulation of the WT1 locus.
    Hewitt JA; Kessler PM; Campbell CE; Williams BR
    Med Pediatr Oncol; 1996 Nov; 27(5):456-61. PubMed ID: 8827074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program.
    Svedberg H; Chylicki K; Baldetorp B; Rauscher FJ; Gullberg U
    Oncogene; 1998 Feb; 16(7):925-32. PubMed ID: 9484784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
    Smith SI; Down M; Boyd AW; Li CL
    Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
    Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1.
    Kim JM; Hong Y; Semba K; Kim S
    Biochem Biophys Res Commun; 2000 Jan; 267(1):59-63. PubMed ID: 10623574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.
    Morris JF; Madden SL; Tournay OE; Cook DM; Sukhatme VP; Rauscher FJ
    Oncogene; 1991 Dec; 6(12):2339-48. PubMed ID: 1662794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.
    McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR
    Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].
    Wu X; Wang Y; Pei X
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):16-9. PubMed ID: 10921096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
    Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
    Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.
    Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH
    Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of WT1 protein in fetal kidneys and Wilms tumors.
    Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
    Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor.
    Menke AL; Shvarts A; Riteco N; van Ham RC; van der Eb AJ; Jochemsen AG
    Cancer Res; 1997 Apr; 57(7):1353-63. PubMed ID: 9102224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines].
    Mi Y; Wang L; Bian S
    Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):627-30. PubMed ID: 11263329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells.
    Gulyás M; Dobra K; Hjerpe A
    Differentiation; 1999 Oct; 65(2):89-96. PubMed ID: 10550542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WT1: what has the last decade told us?
    Little M; Holmes G; Walsh P
    Bioessays; 1999 Mar; 21(3):191-202. PubMed ID: 10333728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter.
    Lee TH; Pelletier J
    Physiol Genomics; 2001 Dec; 7(2):187-200. PubMed ID: 11773605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.